[Skip to the reading](#reading)

Care decisions begin with clear questions

[Irvine Peptide Clinic](/)

An Irvine starting path, one stage after another. Nobody prescribes from this site.

[Back to the starting path](/)

# Follow a claim back to its source

Look for the record that answers your actual question. Different official pages establish different things.

A source is most useful when its date, scope, and limits stay attached to the claim.

On this page

[Match the source to the claim](#note-1)

[A license record concerns a person or business](#note-2)

[Registration does not establish approval](#note-3)

[A report of harm has limits](#note-4)

[Keep the date and the kind of rule](#note-5)

## Match the source to the claim

Begin with the question you are checking. Is the person licensed? Is the exact product approved? What does a California rule require? What supports a claim about a proposed treatment? Those are different questions. Open the linked record and look for the part that answers yours. A government page can be authoritative about its own subject without answering every question about a medicine.

Keep the wording of the claim beside the source. If the source is narrower, keep the narrower meaning. If it describes an allegation, a proposal, or a plan, do not turn it into a completed decision. Ask the person making the claim to show the connection.

## A license record concerns a person or business

California’s consumer affairs search, checked September 28, 2026, reports current, expired, suspended, or revoked status for the license records it covers.

[Source: California license search](https://search.dca.ca.gov/)

The pharmacy board’s verification page also identifies searches for the distinct pharmacy license types.

[Source: State pharmacy search](https://www.pharmacy.ca.gov/about/verify_lic.shtml)

Use that record for the license question. Compare names carefully and read linked documents. Then move to the product question rather than asking the license record to answer it. The license notes and pharmacy notes walk through that split in more detail.

## Registration does not establish approval

The Food and Drug Administration, or FDA, states that registration and drug listing do not denote official approval or permission to market a product, under the rule checked September 26, 2026.

[Source: Federal registration rule](https://www.ecfr.gov/current/title-21/section-207.77)

Its National Drug Code directory likewise says an assigned code does not show that FDA approved the product.

[Source: FDA product-code directory](https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory)

Ask which record supports the claim being made. If someone points to a code when the question was approval, ask for the approval record itself. A listing is still a listing, even when it appears on an official website.

## A report of harm has limits

FDA’s public reporting system says a report does not prove that a drug caused an event, confirm all the information medically, or establish how often the event occurs; this was recorded September 17, 2026.

[Source: FDA limits on event reports](https://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/fda-adverse-event-monitoring-system-aems-public-dashboard)

That limit matters when a number is used to reassure or alarm you. A count without the meaning of the count is an incomplete answer. Ask what was measured and what can actually be concluded. Do not turn a report into proof of cause, or a missing report into proof that no problem exists.

## Keep the date and the kind of rule

The medical boards’ telehealth policy guides state boards. Binding prescribing rules come from state law, rather than this model policy.

[Source: Medical boards’ telehealth policy](https://www.fsmb.org/siteassets/advocacy/policies/fsmb-workgroup-on-telemedicineapril-2022-final.pdf)

California’s questionnaire provision, checked September 26, 2026, permits that route only when the appropriate care standard is met.

[Source: State prior-exam law](https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=2242)

Read the condition with the permission. If a website leaves the condition out, return to the original text. For a personal care decision, take the unresolved point to the professional assessing you and ask how it applies to the exact proposal.

## Continue with a practical check

[Make the first care decision](/field-guide)

Irvine Peptide Clinic

Irvine Peptide Clinic is a guide for the choices before care, not a clinic and never a medicine shop.

## Get oriented

[First care decisions](/field-guide)

[The exact medicine](/medicine-field-notes)

[Compounding](/compounding-field-notes)

## Check the basics

[California checks](/california-field-notes)

[Professional licenses](/license-field-notes)

[Pharmacy checks](/pharmacy-field-notes)

[When to pause](/risk-notes)

## Compare the plan

[Care settings](/care-options-notes)

[Remote visits](/telehealth-field-notes)

[Full costs](/cost-notes)

[Insurance questions](/insurance-notes)

## Prepare to talk

[Visit preparation](/visit-field-notes)

[Common questions](/field-questions)

[Claims and sources](/notes-and-sources)

© Irvine Peptide Clinic

[Read this page as text](/notes-and-sources.md)

[Return to the starting path](/)